EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) earnings per share and revenue

Company revenue for the same period amounts to 2.14 B EGP despite the estimated figure of 2.09 B EGP. Also watch annual changes over time to get a bigger picture of PHAR earnings per share and revenue dynamics.